Evidence map›Paper›PMID 30373565›Full record

ArticleBMC infectious diseases2018

No polymorphisms in K13-propeller gene associated with artemisinin resistance in Plasmodium falciparum isolated from Brazzaville, Republic of Congo.

Pembe Issamou Mayengue, Roch Fabien Niama, Dezi Kouhounina Batsimba, Alida Malonga-Massanga, Igor Louzolo, Nadia Claricelle Loukabou Bongolo, Lucette Macosso, Reyna Ibara Ottia, Ghyslain Kimbassa Ngoma, Louis Régis Dossou-Yovo and 5 more

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 31 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Increase ofJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2024
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Artemisinin resistance: an important emerging clinical problem in tropical medicine.International journal of physiology, pathophysiology and pharmacology · 2021
    Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Pembe Issamou MayengueFaculté des Sciences et Techniques, Université Marien Ngouabi, BP 69, Brazzaville, République du Congo. pmayengue@yahoo.fr.ORCID http://orcid.org/0000-0002-5611-4328
Roch Fabien NiamaFaculté des Sciences et Techniques, Université Marien Ngouabi, BP 69, Brazzaville, République du Congo.
Dezi Kouhounina BatsimbaFaculté des Sciences et Techniques, Université Marien Ngouabi, BP 69, Brazzaville, République du Congo.
Alida Malonga-MassangaFaculté des Sciences et Techniques, Université Marien Ngouabi, BP 69, Brazzaville, République du Congo.
Igor LouzoloLaboratoire National de Santé Publique, BP 120, Brazzaville, République du Congo.
Nadia Claricelle Loukabou BongoloLaboratoire National de Santé Publique, BP 120, Brazzaville, République du Congo.
Lucette MacossoLaboratoire National de Santé Publique, BP 120, Brazzaville, République du Congo.
Reyna Ibara OttiaFaculté des Sciences et Techniques, Université Marien Ngouabi, BP 69, Brazzaville, République du Congo.
Ghyslain Kimbassa NgomaFaculté des Sciences et Techniques, Université Marien Ngouabi, BP 69, Brazzaville, République du Congo.
Louis Régis Dossou-YovoLaboratoire National de Santé Publique, BP 120, Brazzaville, République du Congo.
Brice Pembet SinganaFaculté des Sciences et Techniques, Université Marien Ngouabi, BP 69, Brazzaville, République du Congo.
Gabriel AhomboFaculté des Sciences et Techniques, Université Marien Ngouabi, BP 69, Brazzaville, République du Congo.
Géril Sekangue ObiliCentre Hospitalier Universitaire de Brazzaville, BP 1846, Brazzaville, République du Congo.
Simon Charles KobawilaFaculté des Sciences et Techniques, Université Marien Ngouabi, BP 69, Brazzaville, République du Congo.
Henri Joseph ParraLaboratoire National de Santé Publique, BP 120, Brazzaville, République du Congo.
Laboratoire National de Santé Publique du Congo · CGMarien Ngouabi University · CGCentre Hospitalier et Universitaire de Brazzaville · CG

Funding

The World Academy of Sciences 16-040 RG/BIO/AF/AC_I- FR3240293321
6 · The paper itself

Abstract

backgroundIn the Republic of Congo, artemisinin-based combinations have been recommended for the treatment of uncomplicated malaria since 2006. However, the emergence of resistant parasites again these combinations in Southeast Asia is a threat for the control of this disease, especially in sub-Saharan Africa where the weight of the disease is important. Indeed, polymorphisms in Plasmodium falciparum K13-propeller gene have been involved in variations of drug sensitivity of Plasmodium falciparum to artemisinin-based combinations. The aim of the current study is to determine the prevalence of mutations of this gene in isolates collected in three health centers in Brazzaville.

methodsFrom May 2015 to May 2016, a total of 131, 259 and 416 samples from patients with suspected malaria were collected at the Laboratoire National de Santé Publique, Hôpital de Mfilou, and the CSI «Maman Mboualé» respectively. After DNA isolation, genotyping and sequencing of Plasmodium falciparum K13-propeller were performed in positive Plasmodium falciparum isolates identified after msp-2 gene genotyping.

resultsAll 806 samples collected were msp-2 genotyped and Plasmodium falciparum infections were confirmed in 287 samples with 43, 85, 159 samples from Laboratoire National de Santé Publique, Hôpital de Mfilou, and the CSI «Maman Mboualé» respectively. Of these 287 msp-2 positives samples, K13-propeller nested PCR products were successfully obtained from 145 (50.52%) isolates and sequences were generated from 127(87.58%) nested products. None of mutations that were associated with ACTs resistance in Southeast Asia were detected on the samples from three different study sites from Brazzaville. However, one mutation type was observed at position 578, where alanine was substituted by serine (A578S) in two isolates (1.57%, 2/127), those from the Hôpital de Mfilou. No mutation was found in isolates from the two other sites.

conclusionThe current study shows a very limited polymorphism in the K13-propeller gene in isolates from the Republic of Congo and K13 polymorphisms associate with ACT resistance are not present in this country. However, permanent and large surveillance of resistant parasite population using K13-propeller gene is recommended.

Indexed as

AdolescentAdultAgedAntimalarialsArtemisininsChildCongoDrug ResistanceFemaleGenotypeHumansMalaria, FalciparumMaleMiddle AgedPlasmodium falciparumPolymorphism, GeneticAntimalarialsartemisininArtemisininsProtozoan ProteinsACTsBrazzavilleK13-propeller genePlasmodium falciparumRepublic of CongoResistance

Identifiers

PMID30373565
PMCPMC6206645
OpenAlexW2898907620

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.